Skip to main content
. 2021 Nov 23;20(1):40–47. doi: 10.1016/j.jesf.2021.11.003

Table 1.

Anthropometric, cardiometabolic and dietary outcomes in all groups at baseline and post-intervention (mean ± SD).

HIIT-MICT (n = 11)
HIIT (n = 11)
MICT (n = 10)
CON (n = 10)
ANCOVA
Pre Post Pre Post Pre Post Pre Post P-value η2p
Age (yr) 40.2 ± 5.3 40.5 ± 7.1 40.1 ± 3.6 44.8 ± 6.5
VO2max (mL/min/kg) 34.4 ± 5.0 40.3 ± 4.6∗∗# 34.3 ± 4.4 39.1 ± 5.4∗∗# 34.9 ± 5.0 39.4 ± 7.2∗∗# 36.4 ± 7.2 36.1 ± 7.0 0.009 0.16
HRmax (bpm) 183 ± 10 181 ± 9 181 ± 17 179 ± 17 183 ± 8 181 ± 6 180 ± 8 177 ± 6 0.875 0.02
Exhaustion Time (min) 10.9 ± 0.8 11.7 ± 0.9∗∗# 10.7 ± 1.3 11.4 ± 1.0∗∗# 10.7 ± 1.1 11.4 ± 1.2∗∗# 10.3 ± 1.4 10.0 ± 1.3 0.001 0.17
Maximal speed (mph) 4.3 ± 0.2 4.6 ± 0.4∗∗# 4.3 ± 0.4 4.5 ± 0.4∗∗# 4.4 ± 0.4 4.5 ± 0.4∗∗# 4.2 ± 0.4 4.2 ± 0.4 0.001 0.15
Maximal inclination (%) 16.2 ± 0.6 16.9 ± 1.0∗∗# 16.2 ± 1.1 16.8 ± 1.0∗∗# 16.5 ± 1.0 16.8 ± 1.0∗# 16.0 ± 1.1 16.0 ± 1.1 0.001 0.14
Weight (kg) 77.3 ± 7.4 76.5 ± 7.6∗# 78.3 ± 8.6 77.0 ± 8.2∗# 77.7 ± 11.2 76.5 ± 11.7∗# 80.9 ± 7.2 81.7 ± 7.4 0.025 0.07
BMI (kg·m−2) 26.1 ± 2.2 25.8 ± 2.2∗# 26.3 ± 2.4 25.9 ± 2.3∗# 26.7 ± 2.6 26.3 ± 2.7∗# 26.7 ± 1.6 26.9 ± 1.7 0.025 0.07
Fat (%) 24.0 ± 3.1 23.0 ± 3.4∗∗# 23.9 ± 3.4 22.5 ± 2.9∗∗# 23.9 ± 3.3 22.3 ± 3.7∗∗# 22.7 ± 2.3 22.9 ± 2.6 0.001 0.09
Waist Circumference (cm) 87.5 ± 6.4 85.8 ± 6.2∗∗# 87.0 ± 5.9 85.3 ± 6.0∗∗# 86.8 ± 5.0 84.6 ± 5.1∗∗# 91.4 ± 6.3 91.4 ± 6.2 0.046 0.07
Systolic BP (mm Hg) 123.2 ± 9.6 123.1 ± 11.6 126.1 ± 13.3 121.4 ± 10.1 115.3 ± 10.0 115.0 ± 10.7 127.8 ± 7.0 119.9 ± 8.0 0.074 0.03
Diastolic BP (mm Hg) 79.3 ± 9.6 77.6 ± 8.4 80.1 ± 6.2 76.8 ± 6.8 72.1 ± 6.5 71.4 ± 5.8 80.9 ± 5.3 80.1 ± 7.2 0.837 0.02
Total Cholesterol (mmol/L) 6.02 ± 0.54 5.43 ± 0.53∗ 5.99 ± 0.62 5.73 ± 0.66 5.78 ± 0.58 5.53 ± 0.79 5.60 ± 0.95 5.38 ± 0.59 0.512 0.02
HDL (mmol/L) 1.40 ± 0.36 1.33 ± 0.45 1.31 ± 0.42 1.26 ± 0.35 1.07 ± 0.15 1.10 ± 0.28 1.31 ± 0.45 1.16 ± 0.33 0.450 0.03
Triglyceride (mmol/L) 1.50 ± 0.71 1.40 ± 0.61 1.85 ± 0.76 1.70 ± 0.54 1.77 ± 0.57 1.55 ± 0.60 1.40 ± 0.55 1.53 ± 0.89 0.304 0.02
LDL (mmol/L) 3.93 ± 0.42 3.46 ± 0.68∗ 3.84 ± 0.36 3.69 ± 0.63 3.89 ± 0.56 3.72 ± 0.63 3.47 ± 0.85 3.51 ± 0.69 0.410 0.03
Fasting Glucose (mmol/L) 5.53 ± 0.46 5.65 ± 0.28 5.62 ± 0.56 5.55 ± 0.35 5.32 ± 0.25 5.45 ± 0.24 5.48 ± 0.62 5.39 ± 0.41 0.267 0.03
Fasting insulin (pmol/L) 59.4 ± 29.6 56.4 ± 20.2 54.2 ± 27.0 43.0 ± 8.3∗ 58.7 ± 30.1 60.8 ± 35.7 65.7 ± 29.5 63.7 ± 23.1 0.107 0.06
Insulin resistance (HOMA-IR) 1.14 ± 0.56 1.09 ± 0.38 1.23 ± 0.50 0.83 ± 0.16∗ 1.11 ± 0.55 1.16 ± 0.67 1.25 ± 0.56 1.21 ± 0.43 0.096 0.05
Energy Intake (kcal) 1913 ± 131 1946 ± 123 1878 ± 121 1901 ± 143 1891 ± 135 1924 ± 143 1913 ± 128 1936 ± 130 0.454 0.02
Carbohydrates (g) 253 ± 56 241 ± 52 242 ± 51 237 ± 54 234 ± 56 244 ± 54 248 ± 52 241 ± 57 0.346 0.02
Protein (g) 94 ± 20 101 ± 25 90 ± 20 95 ± 27 96 ± 22 93 ± 22 93 ± 24 101 ± 21 0.746 0.02
Fat (g) 56 ± 18 59 ± 16 61 ± 18 64 ± 13 63 ± 15 64 ± 12 56 ± 12 59 ± 19 0.356 0.03

Note: BMI, body mass index, BP, blood pressure, HDL, high-density lipoprotein cholesterol; HOMA-IR, homeostasis assessment model for insulin resistance; HRmax, maximal heart rate; LDL, low-density lipoprotein cholesterol; VO2max, maximal oxygen uptake.

∗pre vs post (p < 0.05). ∗∗ pre vs post (p < 0.01). # indicates significant group difference compared to CON upon pairwise comparison (p < 0.05).